Kisvarda, Hungary

Zoltan Kovacs


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zoltan Kovacs: Innovator in Pharmaceutical Chemistry

Introduction: Zoltan Kovacs is a notable inventor from Kisvarda, Hungary, known for his contributions to the field of pharmaceutical chemistry. With a focus on innovative compounds, he has developed patents that aim to enhance medical treatments and address important health challenges.

Latest Patents: Zoltan Kovacs holds a patent for "1,4,10,13-tetraoxa-7,16-diazacyclooctadecane derivatives." This invention pertains to partially novel metal complexes, salts, and double salts of 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane compounds. The patent offers a comprehensive formula that includes various substituents and modifications designed to improve the efficacy of pharmaceutical applications.

Career Highlights: Kovacs has an impressive background, having worked with significant institutions such as the National "Frédéric Joliot-Curie" Institute of Sugar Biology and Health and Kossuth Lajos University. His experiences in these organizations have enabled him to hone his skills in research and development, contributing to advancements in his field.

Collaborations: Throughout his career, Zoltan Kovacs has had the pleasure of collaborating with esteemed colleagues, including Laszlo Varga and Laszlo B. Sztanyik. These partnerships have facilitated the exchange of ideas and have been instrumental in driving forward innovative projects in pharmaceutical research.

Conclusion: Zoltan Kovacs stands out as an influential figure in the pharmaceutical industry, with a focus on innovative compounds that have the potential to transform medical treatments. His patent signifies a step forward in the field, showcasing his commitment to advancing healthcare solutions through ingenuity and collaboration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…